NVIDIA Stock Slides 16% Over 6 Straight Down Days

NVDAYTD-21.5%SPYYTD+5.8%QQQYTD+5.4%
Analyze NVDA →

Today’s big story: Will 2027 Be A 2022 Repeat For Stocks?

NVIDIA (NVDA) stock is on a 6-day losing streak, down 16.0% since the run began. That erased about $671.3 billion from the company’s market value, which now stands at about $3.53 trillion. The stock closed at $145.98 on Thursday, November 19, its lowest close of the past year.

Image from Pixabay

 
The Streak Next To The S&P 500

Returns for NVDA and the S&P 500 over the streak and the periods around it, all ending Thursday, November 19 and including dividends:
 

Return Period NVDA S&P 500
1 Day -3.3% -2.0%
6 Days (Current Streak) -16.0% -5.8%
1 Month (21 Trading Days) -34.2% -7.4%
3 Months (63 Trading Days) -31.9% -6.2%
Year To Date -21.5% 5.9%
1 Year (252 Trading Days) -19.3% 9.7%

Is This Move About NVIDIA Or The Market?

The market explains little of this: the S&P 500 lost 5.8% over the same 6 sessions, including dividends, against NVIDIA’s -16.0%. 25 other S&P 500 stocks are currently on losing streaks of 6 days or longer. Over the past three months the stock is down 31.9%, a window that includes the streak; over the other 57 sessions of that window it was down 19.0%.

What The Numbers Say About The Slide

On the fundamentals, revenue grew 83.4% over the last twelve months, against a median of 17.9% for S&P 500 Information Technology stocks; its operating margin is 65.2%, versus a median of 21.5%; and the stock trades at 18.3 times trailing earnings against a median of 28.0. The selling is hard to square with the fundamentals: revenue growth above the median, margins above the median and a multiple below the median.

A slide like this raises an obvious follow-up: which marked-down stocks are actually worth buying? Our Buy the Dip screen runs that test every day, flagging beaten-down names whose fundamentals still hold up.

For anyone who would rather back the theme than one company, a semiconductor ETF like SMH holds the whole group, not just this stock. It is still a concentrated bet on one theme, which is the gap the portfolio below is built to close.

Weakness In One Name Should Be Noise, Not News

For a diversified holder, a streak like this is a data point. For a concentrated one, it is a hole in the plan. The difference is never the stock; it is the portfolio built around it.

Building that portfolio is what the Trefis High Quality (HQ) Portfolio does: roughly 30 businesses with the cash generation and balance-sheet strength to absorb a bad month, selected and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Make the next streak, in either direction, someone else’s drama.